Aciont gets $214K; Starpharma appoints exec;

> Aciont, based in Salt Lake City, has received $214,000 from the National Eye Institute and the National Institutes of Health to look into its ocular drug delivery system. Release

> Beginning in February 2011, Springer will launch a new peer-reviewed journal Drug Delivery and Translational Research, which will publish research on topics such as designing and developing novel drug delivery systems. Release

> Australia-based Starpharma has appointed Malcolm McColl to join the company's business development team as a vice president to meet the growing market demand for the company's dendrimer technology for drug delivery. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.